Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Amwell partners with CVS, reports 10% subscription revenue increase for Q2

The news: During its Q2 2022 earnings call on August 4, Amwell said it will partner with CVS on the retailer’s new Virtual Primary Care service.

Alongside the news: Despite telehealth usage declining overall, Amwell reported a 7% annual increase in revenues, hitting $64.5 million for Q2 2022, up from $60.2 million in Q2 2021.

  • Amwell also achieved a 10% subscription revenue increase for Q2, up to $29.6 million from $26.8 million in Q2 2021.
  • Amwell says its total virtual care visits totaled more than 1.5 million in Q2 2022 compared with 1.3 million in Q2 2021.

How we got here: CVS announced in May that it will launch its virtual care platform next year. Aetna plan sponsors and clients of CVS pharmacy benefits manager Caremark will have access to the platform.

  • In April 2021, Amwell launched its Converge technology platform to enable care in person, remotely, and through automation.
  • CVS will open up its virtual solution to Aetna members in 2023.

Trendspotting: Despite the growth of partnerships with pharmacies, and the rising numbers from Amwell, telehealth use has been dropping overall this year.

  • US adults telehealth use (measured by medical claim lines) decreased 6.1% in March, according to nonprofit Fair Health.

What’s next? We’re watching the competition between two virtual care platforms: Amwell’s Converge and Teladoc’s Primary360.

For context, CVS is already working with Teladoc on a virtual care solution, offering it to self-funded employers. So, CVS now has deals with both companies.

Although Teladoc is expanding its Primary360 platform, it posted a steep loss of $3.1 billion in Q2. The race is on to see who will develop stronger relationships with pharma, and with the deep amount of integrations that Amwell Converge offers, Amwell should be well positioned for more pharma deals in primary care.

In the earnings call, Amwell CEO Ido Schoenberg hinted at more integrations to come as its platform will serve as a layer to connect patients, providers, payers, and employers.

Go deeper: Check out our US Telehealth Trends 2022 report.

This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account